ACE and COVID-19: The respective activities, however, increased in the recovery phase, and the authors concluded that serum ACE activity could be potentially used as a marker reflecting COVID-19 severity, since low activity was associated with the severity of COVID-19 at baseline, and the activity increased with the remission of the disease [244].